Cancer‐associated V‐ATPase induces delayed apoptosis of protumorigenic neutrophils
Tumors and neutrophils undergo an unexpected interaction, in which products released by tumor cells interact to support neutrophils that in turn support cancer growth, angiogenesis, and metastasis. A key protein that is highly expressed by cancer cells in tumors is the a2 isoform V‐ATPase (a2V). A p...
Main Authors: | Safaa A. Ibrahim, Arpita Kulshrestha, Gajendra K. Katara, Valerie Riehl, Manoranjan Sahoo, Kenneth D. Beaman |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-03-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.12630 |
Similar Items
-
In vivo anti‐V‐ATPase antibody treatment delays ovarian tumor growth by increasing antitumor immune responses
by: Arpita Kulshrestha, et al.
Published: (2020-10-01) -
Vacuolar Membrane ATPase Activity 21 Predicts a Favorable Outcome and Acts as a Suppressor in Colorectal Cancer
by: Fan Zhang, et al.
Published: (2021-02-01) -
Identification of Novel Bisbenzimidazole Derivatives as Anticancer Vacuolar (H+)-ATPase Inhibitors
by: Renukadevi Patil, et al.
Published: (2017-09-01) -
The curious case of vacuolar ATPase: regulation of signaling pathways
by: Sahithi Pamarthy, et al.
Published: (2018-02-01) -
Effects of proton pump inhibitors on reversing multidrug resistance via downregulating V-ATPases/PI3K/Akt/mTOR/HIF-1α signaling pathway through TSC1/2 complex and Rheb in human gastric adenocarcinoma cells in vitro and in vivo
by: Chen M, et al.
Published: (2018-10-01)